2016-05-25-RDI-main-article-image

Three Berkshire Hathaway Investments You Should Take a Closer Look At!

New York, New York – May 25th, 2016 – Berkshire Hathaway has averaged a 19.7% annual growth in book value to shareholders over the last 49 years, which is more than double the S&P 500’s return, including dividends, over the same period.
Read More

Biotech Industry Positioned for a Potential Breakout in 2017: Today’s Reports on Array Biopharma and Opko Health

Biotech stocks have continued to outperform the broader markets in 2017 as an expectation of easier regulatory environment and growing speculation of mergers & acquisitions speculation have combined to provide the potential for a breakout year for the industry. The iShares NASDAQ Biotechnology Index ETF and the SPDR S&P Biotech ETF have posted year-to-date gains of 10.4 percent and 16.1 percent, respectively, compared to gains of 4.34 percent and 4.84 percent for the Dow and the S&P 500. read more

Easier Regulatory Environment Could Send Biotech Industry Skyrocketing in 2017: Today’s Reports on Neuralstem and Exelixis

Biotech stocks have continued to outperform the broader markets in 2017 as an expectation of easier regulatory environment and growing speculation of mergers & acquisitions speculation have combined to provide the potential for a breakout year for the industry. The iShares NASDAQ Biotechnology Index ETF and the SPDR S&P Biotech ETF have posted year-to-date gains of 10.4 percent and 16.1 percent, respectively, compared to gains of 4.34 percent and 4.84 percent for the Dow and the S&P 500. read more

Today’s Reports on Trending Tickers Superconductor Technologies and Power Solutions International

U.S. markets pulled back slightly from their record highs Thursday as President Donald Trump failed to provide any more details regarding his “phenomenal” tax plan and instead announced a proposed replacement for the Affordable Care Act, aka Obamacare, would be submitted March before any tax reform. All three major indexes closed at record highs for the fifth consecutive day on Wednesday, marking the first time this has happened since January 1992. read more

Mining Stocks Pull Back as Commodity Prices Slip: Today’s Research Reports on Teck Resources and Freeport-McMoRan

Mining stocks pulled back Thursday as the prices of industrial metals fell, despite a rise in gold prices. Copper prices have continued to slide since Tuesday as a strengthening U.S. dollar and signs of a strengthening U.S. economy have put some downward pressure on prices. On Thursday, three-month copper prices on the London Metal Exchange fell 0.40 percent to $6,028.50 a metric ton, just days after hitting a 20-month high of $6,200 a metric ton. Prices for the metal are still up roughly 9 percent in 2017. read more

Biotech Industry Shaping up to Have a Breakout Year in 2017: Today’s Reports on Insys Therapeutics and Zosano Pharma

Biotech stocks have continued to outperform the broader markets in 2017 as an expectation of easier regulatory environment and growing speculation of mergers & acquisitions speculation have combined to provide the potential for a breakout year for the industry. The iShares NASDAQ Biotechnology Index ETF and the SPDR S&P Biotech ETF have posted year-to-date gains of 11.1 percent and 16.8 percent, respectively, compared to gains of 4.3 percent and 4.93 percent for the Dow and the S&P 500. read more

Biotech Industry Poised for a Breakout in 2017? Today’s Reports on Evoke Pharma and Novavax

Biotech stocks have continued to outperform the broader markets in 2017 as an expectation of easier regulatory environment and growing speculation of mergers & acquisitions speculation have combined to provide the potential for a breakout year for the industry. The iShares NASDAQ Biotechnology Index ETF and the SPDR S&P Biotech ETF have posted year-to-date gains of 11.1 percent and 16.8 percent, respectively, compared to gains of 4.3 percent and 4.93 percent for the Dow and the S&P 500. read more